ArticleTranslational lung cancer research2025
Risk factors behind the global lung cancer burden: a pan-database exploration.
Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Predictors of prolonged hospital stay in patients with lung cancer undergoing sublobar resection.Translational lung cancer research · 2026Article
- Associations of lung and bronchus cancer incidence and ambient temperature and severe drought: a population-based study.BMC public health · 2026Observational
- The potential utility of in-silico approach in identifying phytochemicals against various targets for the management of lung cancer.Discover oncology · 2026Review
- Predicting pulmonary nodule growth from a single time point: a fusion model of radiomics and deep learning to optimize follow-up strategies.Journal of thoracic disease · 2026Article
- Association between a radical urbanization index and lung disease risk in China: longitudinal evidence from the CHARLS.BMC cancer · 2026Article
- Lung Cancer Risk Factors Beyond Smoking in Ethiopia: A Multicenter Matched Case-Control Study.Cancers · 2026Article
- Article
- Patient profiles, incidence and trends of lung cancer in Ethiopia from 2012 to 2023 using a cancer registry.Scientific reports · 2026Article
- Lung Cancer in Never-Smokers: Risk Factors, Driver Mutations, and Therapeutic Advances.Diagnostics (Basel, Switzerland) · 2026Review
- Use of preoperative placement of mini-midline catheters in patients undergoing thoracoscopic lung resection.Scientific reports · 2026Article
- Machine Learning Prediction of Prolonged Length of Stay in Older Patients with Lung Cancer: A Multicenter Study Using XGBoost with SHAP Interpretation.Cancer management and research · 2026Article
- Integrated molecular dynamics elucidation of TP53 H179 zinc-binding variants: genomic and structural characterization across NSCLC subtypes.Frontiers in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is the leading cause of cancer-related morbidity and mortality worldwide. Understanding its multifactorial risk factors is crucial for effective prevention strategies. While tobacco smoking remains the primary risk factor, the roles of other factors are less well understood across different global settings. This study aimed to provide a comprehensive analysis of global lung cancer trends from 1990 to 2021, examining associations between lung cancer outcomes and diverse environmental, socioeconomic, lifestyle, and dietary factors across 201 countries. Methods: We conducted a comprehensive analysis of lung cancer prevalence and mortality from 1990 to 2021 across 201 countries, utilizing data from multiple international databases, including the Global Burden of Disease Study and the World Health Organization. We assessed associations between lung cancer outcomes and various environmental, socioeconomic, lifestyle, and dietary factors using correlation analysis, generalized linear models, and canonical correlation analysis. Results: Globally, lung cancer cases increased from 1.40 million in 1990 to 3.25 million in 2021, while age-standardized prevalence remained relatively stable. Smoking showed the strongest correlation with lung cancer prevalence (r=0.753, P<0.001), with urbanization also showing a significant positive association (r=0.481, P<0.001). Ambient temperature was negatively correlated with lung cancer prevalence (r=-0.296, P<0.001). Cooking methods influenced risk: gas cooking was associated with lower lung cancer prevalence compared to biomass cooking. These findings highlight the complex interplay of factors influencing lung cancer risk globally. Conclusions: While smoking remains the predominant risk factor for lung cancer, other factors such as urbanization, ambient temperature, and cooking methods significantly influence global prevalence patterns. Our study underscores the need for comprehensive public health strategies that address environmental and lifestyle factors alongside traditional risk factors. These insights are critical for informing targeted interventions aimed at reducing the global burden of lung cancer, especially in the context of rapid urbanization and climate change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.